Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Encouraging results from Nymox's phase III reinjection study of NX-1207

Jan. 23, 2013

FDA approves Botox for overactive bladder

Jan. 21, 2013

Kyorin and Daiichi Sankyo terminate imidafenacin agreement in Brazil

Jan. 18, 2013

Enrollment open in phase II study of Bendavia

Jan. 17, 2013

Eli Lilly presents novel aldosterone synthase inhibitors

Jan. 15, 2013

Mirabegron approved in Europe

Jan. 14, 2013

OPKO Health to expand pipeline with acquisition of Cytochroma

Jan. 11, 2013

Phase I RenaZorb data support further development

Jan. 10, 2013

Japan Tobacco files JTT-751 NDA in Japan

Jan. 8, 2013

Proteon Therapeutics reports results from study of recombinant human elastase

Jan. 7, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...